Gado, Ahmed S <br/><br/>
Dexamethasone intravitreous implant versus bevacizumab for central retinal vein occlusion-related macular oedema: a prospective randomized comparison.  [electronic resource] 

 -  Clinical & experimental ophthalmology   
 - 650-5 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>1442-9071 
<br/><br/><label>Standard No.: </label>10.1111/ceo.12311  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Angiogenesis Inhibitors--therapeutic use<br/>Antibodies, Monoclonal, Humanized--therapeutic use<br/>Bevacizumab<br/>Dexamethasone--administration & dosage<br/>Drug Implants<br/>Female<br/>Fluorescein Angiography<br/>Glucocorticoids--administration & dosage<br/>Humans<br/>Intraocular Pressure<br/>Intravitreal Injections<br/>Macular Edema--drug therapy<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Retinal Vein Occlusion--complications<br/>Tomography, Optical Coherence<br/>Vascular Endothelial Growth Factor A--antagonists & inhibitors<br/>Visual Acuity--drug effects